Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Nektar Therapeutics describes activity of autoimmune disease candidate NKTR-358

July 12, 2017

FDA designates tadekinig alfa an orphan treatment for Still's disease

July 10, 2017

Sirukumab named orphan drug in the U.S. for juvenile idiopathic arthritis

July 10, 2017

Padlock Therapeutics patents protein-arginine deiminase type-4 inhibitors

July 7, 2017

FDA approves Bristol-Myers Squibb's Orencia in psoriatic arthritis

July 7, 2017

Innocare initiates phase I trial of ICP-022

July 6, 2017

Daiichi Sankyo discontinues Japanese development of etanercept biosimilar CHS-0214

July 5, 2017

Japan's MHLW approves Olumiant for rheumatoid arthritis

July 4, 2017

Pralia approved for additional indication in Japan

July 4, 2017

Celgene's CC-220 shows promise in phase II SLE study

July 4, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...